Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons

被引:28
|
作者
Hinman, Melissa N. [1 ]
Sharma, Alok [1 ]
Luo, Guangbin [1 ,3 ]
Lou, Hua [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA
基金
美国国家卫生研究院;
关键词
GTPASE-ACTIVATING PROTEIN; PRE-MESSENGER-RNA; EMBRYONIC STEM-CELLS; GAP-RELATED DOMAIN; GENE-PRODUCT; POLYPYRIMIDINE TRACT; MOUSE MODEL; NF1; GENE; LEARNING-DEFICITS; DEVELOPMENTAL REGULATION;
D O I
10.1128/MCB.00019-14
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis type I (Nf1) is a GTPase-activating protein (GAP) that inactivates the oncoprotein Ras and plays important roles in nervous system development and learning. Alternative exon 23a falls within the Nf1 GAP domain coding sequence and is tightly regulated in favor of skipping in neurons; however, its biological function is not fully understood. Here we generated mouse embryonic stem (ES) cells with a constitutive endogenous Nf1 exon 23a inclusion, termed Nf1 23aIN/23aIN cells, by mutating the splicing signals surrounding the exon to better match consensus sequences. We also made Nf1 23a Delta/23a Delta cells lacking the exon. Active Ras levels are high in wild-type (WT) and Nf1 23aIN/23aIN ES cells, where the Nf1 exon 23a inclusion level is high, and low in Nf1 23a Delta/23a Delta cells. Upon neuronal differentiation, active Ras levels are high in Nf1 23aIN/23aIN cells, where the exon inclusion level remains high, but Ras activation is low in the other two genotypes, where the exon is skipped. Signaling downstream of Ras is significantly elevated in Nf1 23aIN/23aIN neurons. These results suggest that exon 23a suppresses the Ras-GAP activity of Nf1. Therefore, regulation of Nf1 exon 23a inclusion serves as a mechanism for providing appropriate levels of Ras signaling and may be important in modulating Ras-related neuronal functions.
引用
收藏
页码:2188 / 2197
页数:10
相关论文
共 50 条
  • [21] The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1
    Barkan, Batya
    Starinsky, Sigal
    Friedman, Eitan
    Stein, Reuven
    Kloog, Yoel
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5533 - 5542
  • [22] Expression of Ras signaling pathway proteins and developmental factors in peripheral nerve sheath tumors of patients with neurofibromatosis type 1
    Hagel, Christian
    Noernberg, Louisa K. N.
    Friedrich, Reinhard E.
    CLINICAL NEUROPATHOLOGY, 2023, 42 (04) : 150 - 160
  • [23] Dysregulation of alternative splicing in spinocerebellar ataxia type 1
    Olmos, Victor
    Thompson, Evrett N.
    Gogia, Neha
    Luttik, Kimberly
    Veeranki, Vaishnavi
    Ni, Luhan
    Sim, Serena
    Chen, Kelly
    Krause, Diane S.
    Lim, Janghoo
    HUMAN MOLECULAR GENETICS, 2024, 33 (02) : 138 - 149
  • [24] Nova1 is a master regulator of alternative splicing in pancreatic beta cells
    Villate, Olatz
    Turatsinze, Jean-Valery
    Mascali, Loriana G.
    Grieco, Fabio A.
    Nogueira, Tatiane C.
    Cunha, Daniel A.
    Nardelli, Tarlliza R.
    Sammeth, Michael
    Salunkhe, Vishal A.
    Esguerra, Jonathan L. S.
    Eliasson, Lena
    Marselli, Lorella
    Marchetti, Piero
    Eizirik, Decio L.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (18) : 11818 - 11830
  • [25] Lisch Nodules: A Key Diagnostic Sign of Neurofibromatosis Type 1
    Rodriguez-Lomba, E.
    Lozano-Masdemont, B.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (05): : 459 - 460
  • [26] Neurofibromatosis type 1 (NF1) gene: alternative splicing of exons 29 and 30 and a novel brain-specific transcript.
    Park, VM
    Pivnick, EK
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A180 - A180
  • [27] Bub1 is a key regulator of TGF-β signaling
    Nyati, Shyam
    Schinske-Sebolt, Katrina
    Pitchiaya, Sethuramasundaram
    Chekhovskiy, Katerina
    Chator, Areeb
    Chaudhry, Nauman
    Dosch, Joseph
    Van Dort, Marcian E.
    Varambally, Sooryanarayana
    Kumar-Sinha, Chandan
    Nyati, Mukesh K.
    Ray, Dipankar
    Walter, Nils G.
    Yu, Hongtao
    Ross, Brian D.
    Rehemtulla, Alnawaz
    CANCER RESEARCH, 2014, 74 (19)
  • [28] YB-1, a key regulator of androgen receptor signaling
    Rockstroh, Anja
    Pokorny, Morgan R.
    Lehman, Melanie
    Walker, Chelsea
    Nelson, Colleen C.
    BJU INTERNATIONAL, 2015, 116 : 45 - 45
  • [29] Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders
    Kaczorowski, Jessica A.
    Smith, Taylor F.
    Shrewsbury, Amanda M.
    Thomas, Leah R.
    Knopik, Valerie S.
    Acosta, Maria T.
    BEHAVIOR GENETICS, 2020, 50 (04) : 191 - 202
  • [30] Neurofibromatosis type 1 peripheral nerve tumors: Aberrant activation of the Ras pathway
    Feldkamp, MM
    Angelov, L
    Guha, A
    SURGICAL NEUROLOGY, 1999, 51 (02): : 211 - 218